Lycopus Virginicus is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Hahnemann Laboratories, Inc.. The primary component is Lycopus Virginicus.
| Product ID | 37662-1037_e46d7b97-594d-3492-e053-2995a90acd6d |
| NDC | 37662-1037 |
| Product Type | Human Otc Drug |
| Proprietary Name | Lycopus Virginicus |
| Generic Name | Lycopus Virginicus |
| Dosage Form | Pellet |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-07-22 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / |
| Labeler Name | Hahnemann Laboratories, INC. |
| Substance Name | LYCOPUS VIRGINICUS |
| Active Ingredient Strength | 6 [hp_C]/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-07-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0220-3189 | Lycopus virginicus | LYCOPUS VIRGINICUS |
| 0220-3194 | Lycopus virginicus | LYCOPUS VIRGINICUS |
| 15631-0279 | LYCOPUS VIRGINICUS | LYCOPUS VIRGINICUS |
| 15631-0628 | LYCOPUS VIRGINICUS | LYCOPUS VIRGINICUS |
| 37662-1037 | Lycopus Virginicus | Lycopus Virginicus |
| 37662-1038 | Lycopus Virginicus | Lycopus Virginicus |
| 37662-1039 | Lycopus Virginicus | Lycopus Virginicus |
| 37662-1040 | Lycopus Virginicus | Lycopus Virginicus |
| 37662-1041 | Lycopus Virginicus | Lycopus Virginicus |
| 37662-1042 | Lycopus Virginicus | Lycopus Virginicus |
| 37662-1043 | Lycopus Virginicus | Lycopus Virginicus |
| 37662-1044 | Lycopus Virginicus | Lycopus Virginicus |
| 68428-486 | Lycopus virginicus | LYCOPUS VIRGINICUS |
| 71919-430 | Lycopus virginicus | LYCOPUS VIRGINICUS |
| 64117-258 | COUGH HEADACHE | LYCOPUS VIRGINICUS |